Dr. Christopher Potrykus, D.D.S. Dentist Medicare: Medicare Enrolled Practice Location: 920 Indian Spring Dr, Delafield, WI 53018 Phone: 262-646-2771 |
Dr. Ann Marie Brobson, D.D.S. Dentist Medicare: Not Enrolled in Medicare Practice Location: 920 Indian Spring Dr, Delafield, WI 53018 Phone: 262-646-2771 |
Dr. Thomas L Wavernek, DDS Dentist - General Practice Medicare: Not Enrolled in Medicare Practice Location: 920 Indian Spring Dr, Delafield, WI 53018 Phone: 262-646-2771 |
Dr. Michelle J Kelly, D.D.S. Dentist - General Practice Medicare: Not Enrolled in Medicare Practice Location: 11 Crossroads Ct, Delafield, WI 53018 Phone: 262-646-4188 Fax: 262-646-4181 |
Dr. Mark R Knutson, DDS Dentist - General Practice Medicare: Not Enrolled in Medicare Practice Location: 920 Indian Spring Dr, Delafield, WI 53018 Phone: 262-646-2771 |
Dr. David M Schlaack, DDS Dentist Medicare: Not Enrolled in Medicare Practice Location: 11 Crossroads Ct, Delafield, WI 53018 Phone: 262-646-4188 |
Dr. Christopher Visaya Dentist - General Practice Medicare: Medicare Enrolled Practice Location: 3210 Golf Rd, Delafield, WI 53018 Phone: 262-646-8333 Fax: 262-646-2410 |
Dr. Thomas E Kielma, D.D.S. Dentist - General Practice Medicare: Not Enrolled in Medicare Practice Location: 524 Milwaukee St, Suite 200, Delafield, WI 53018 Phone: 262-646-7717 Fax: 262-646-7871 |
News Archive
GTx, Inc. today provided a company update and reported financial results for the fourth quarter and full year 2009.
Now, a team of researchers at the Karolinska Institutet and Karolinska University Hospital in Sweden has found that the number of people immune to COVID-10 may be higher than previously thought, and that antibody testing may no longer be the appropriate tool to trace it.
Wyeth Pharmaceuticals, a division of Wyeth, announces findings from a placebo-controlled Phase 3 study of bazedoxifene 20 mg extended to five years, which indicated a significant reduction versus placebo in new vertebral fractures in postmenopausal women with osteoporosis.
Tear osmolarity is a poor indicator of treatment response in patients with dry eye disease (DED), suggests research published in the American Journal of Ophthalmology.
› Verified 1 days ago